Professor Giulio Tarro has been appointed chief Editor of Vaccine Research and Development (VRD), which is run by Whioce Publishing Pte. Published as an international peer-reviewed open access journal. Co., LTD.

Dr. Tarro has been engaged in medical research for more than 30 years. He was born on 9 July 1938 in Messina, Sicily, where he attended high school and began his medical studies at the University of Messina in 1956, then continued his medical studies at the University of Naples in 1960 where he obtained his M.D. “with distinction” in 1962 and served as professor of Oncology virology in 1972.

His research work began in 1960 in the Virology laboratory of the Department of Medical Pathology at the University of Naples and continued throughout the medical research period. In I963 and 1964, he trained in pathology, neurology and internal medicine at the General Hospital of the University of Naples. In 1965, he went to the University of Cincinnati Children’s Hospital Research Foundation, where he served for three years as a research assistant with Dr. Albert B. Sabin, followed by assistant professor of Research Pediatrics in 1968 and 1969. At the university. From there, Dr. Tarro returned to Naples and, with the help of a research contract from the National Cancer Institute (United States), established the virology laboratory at the Infectious Disease Hospital. Dr. Tarro was a senior scientist at the Frederick Cancer Research Center in 1973 when he was a special adviser to the National Cancer Institute, Dr. Albert Sabin. He is best known for his work that provided experimental evidence of a link between the herpes virus and cervical cancer. Although initially controversial, the work has been carried out by several laboratories using different techniques.

Dr Tarro’s research in virology is both fundamental and mission-oriented. His basic research has focused on antigens induced early in the replication cycle of herpes simplex virus (HSV). Specific antibodies are detected by enzyme-linked immunosorbent assay in sera of patients with certain cancers of the head, neck, and urogenital tract. His task-oriented research covers many aspects of various infectious diseases, including bronchopneumonia, encephalitis, cholera and diseases caused by different viruses.

During 1979 he was engaged in research on an epidemic disease in Naples called the “dark disease”. Dr Tarro isolated the respiratory syncytial virus (RSV) and found antibody evidence that this virus was behind the epidemic. The World Health Organization expert were called in and agreed most cases of disease were caused by RSV. In 1981 he suggested the proper use of interferon to cure the cytomegalovirus infection affecting the pope John Paul the second who underwent long surgical operation and received huge blood transfusion after the killing attempt.

Dr Tarro is currently engaged in scientific research related to the separation and identification of tumour antigens present on cell membranes and their potential value in immunotherapy for cancer. He has shown that specific soluble antigens may be used in various tests for a further understanding of their role in various cancer systems. Another study has involved the identification, isolation and characterization of specific virus-induced tumour antigens, which were the “finger-prints” left behind in tumours induced in man by human herpes viruses. Intramural activities have included being director of thesis and research  for many candidates; director of medical research fellowships for medical  students; participation in research planning for clinical colleagues; teaching  virology, oncology and immunology to medical and graduate students.

He is on the editorial board of various Italian medical journals. Dr Tarro has been elected to membership of many academies and societies. He has also been the recipient of many awards and honours.  Dr Tarro is life president of the T. and L. de Beaumont Bonelli Foundation for Cancer Research officially recognized by Italian presidential decree n. 36 of January 3, 1978. The aim of the Foundation is the promotion of scientific research on cancer and was instituted thanks to the generous donation of the late Teresa Berger who left to the foundation a large part of her patrimony, whereas the late husband, the Earl Luigi de Beaumont Bonelli, left most of his patrimony to the Nobel foundation.

Dr. Tarro became director of the Department of Virology (1973-2003) and then director of the Department of diagnostic Laboratories (2003-2006) at the D. Cotugno Hospital for Infectious Diseases in Naples; Emeritus, 2006. He is the Scientific Coordinator of in vitro hyperthermia for PATIENTS with HCV, First Circle Medicine, Minneapolis (2000-2003). Since 2007, he has served as a member of the UNESCO Biotechnology and VirusSphere World Academy Chair committee for Biomedical Technology and as an adjunct Professor in the School of Science and Technology at Temple University in Philadelphia, USA.